Mylan recalls anxiety medication due to ‘foreign material’

By Ben Hargreaves

- Last updated on GMT

(Image: Getty/Gustavofrazao)
(Image: Getty/Gustavofrazao)

Related tags Recall Mylan Alprazolam

A voluntary recall of one lot of alprazolam tablets was announced by Mylan, after the potential presence of contaminant was discovered.

The adulterating substance, which was only identified as a ‘foreign substance’, led to a voluntary recall from the consumer level of one lot of alprazolam tablets 0.5mg.

The product is more commonly known by its branded name, Xanax, and is a treatment for anxiety and panic disorders.

Mylan noted in its release that any ‘clinical impact’ from the foreign material present is ‘expected to be a rare’, though it did indicate that there is a potential risk of infection that could not be ruled out.

The affected batch was distributed in the US between July and August 2019.

The company stated that it had notified distributors and customers of its decision to recall product.

Earlier this year​, Mylan had also issued a recall of two lots of levoleucovorin injection, after stability testing revealed that copper salts were present in the sterile injectable.

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us